Advertisement
Home 2018

Archives

An artificial intelligence-based smartphone app can reduce the severity of cancer patients' reported pain and hospital admissions

AI-Based Smartphone App Can Help Cut Cancer Pain Severity

0
App can cut both severity of advanced cancer patients' reported pain and hospital admissions
Women aged 75 years and older can still benefit from routine mammography

RSNA: Mammography Has Value in Women Age 75 or Older

0
Cancer detection rate is 8.4/1,000 exams in older women; 98 percent of cancers surgically excised
Adverse events for immune checkpoint inhibitors used to treat non-small cell lung cancer may be more common in real-world settings than reported in the clinical trials that led to U.S. Food and Drug Administration approvals

Immunotherapy Side Effects May Be More Common Than Thought

0
Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings
The ultrasound appearance of an echogenic deltoid muscle may predict diabetes and prediabetes

RSNA: Ultrasound of Shoulder Muscle May Help Diagnose T2DM

0
Echogenic-appearing deltoid muscle appears to be a powerful predictor of diabetic status
Patients with peanut allergy who received oral immunotherapy

ACAAI: Oral Immunotherapy Is Protective in Peanut Allergy

0
More patients receiving AR101 able to ingest ≥600 mg peanut protein without dose-limiting symptoms
Almost 2 percent of children in the United States have a milk allergy

ACAAI: Almost 2 Percent of Children Have Milk Allergy

0
Among children with food allergy, 53 percent of infants have milk allergy vs. 15 percent of teens
For children hospitalized with asthma exacerbations

ACAAI: Hospital Stay, Caregiver Knowledge of Asthma Linked

0
Children of caregivers with poor asthma knowledge more likely to have prolonged hospital stay
Both hospitalizations and deaths are increasing among Medicare recipients with liver cancer

Burden of Liver Cancer Rising in Medicare Patients

0
Coexistence of other liver conditions tied to even higher risk for death, health care costs
Combined treatment with glecaprevir and pibrentasvir is highly effective in treating chronic hepatitis C virus genotype-1 infections that failed to respond to direct-acting antiviral therapy

Option Found for Retreatment of Chronic Hep C Infection

0
Glecaprevir + pibrentasvir effective for those who previously failed direct-acting antiviral treatment
For patients with diabetes mellitus with multivessel coronary disease

AHA: Lasting Benefit for CABG in Diabetes, Multivessel Disease

0
Lower all-cause mortality in CABG group versus PCI-DES group after median follow-up of 7.5 years